Insiders · Profile

Lee Sung

EVP, Chief Financial Officer at CYTOKINETICS · EVP & Chief Financial Officer at Vir Biotechnology. Filing since 27 Mar 2024. CIK 0001793200

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jul 2026
EVP, Chief Financial Officer
Sold on a plan
1,112
$97.62K
1.7%
29 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
3,134
$266.39K
4.7%
24 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
38,730
$3.19M
38.0%
5 May 2026
EVP, Chief Financial Officer
Sold on a plan
23,906
$1.84M
27.4%
17 Mar 2026
EVP, Chief Financial Officer
Sold at will
4,935
$306.71K
5.4%
27 Mar 2024
EVP & Chief Financial Officer
Sold at will
6,008
$59.40K
5.6%
6 decisions on file.